TWM464150U - Microcapsule dressing containing stem cell conditioned medium composition liquid - Google Patents
Microcapsule dressing containing stem cell conditioned medium composition liquid Download PDFInfo
- Publication number
- TWM464150U TWM464150U TW102210016U TW102210016U TWM464150U TW M464150 U TWM464150 U TW M464150U TW 102210016 U TW102210016 U TW 102210016U TW 102210016 U TW102210016 U TW 102210016U TW M464150 U TWM464150 U TW M464150U
- Authority
- TW
- Taiwan
- Prior art keywords
- dressing
- skin
- conditioned medium
- microcapsule
- microcapsule dressing
- Prior art date
Links
- 239000003094 microcapsule Substances 0.000 title claims description 63
- 239000003636 conditioned culture medium Substances 0.000 title claims description 35
- 239000000203 mixture Substances 0.000 title claims description 12
- 210000000130 stem cell Anatomy 0.000 title claims description 7
- 239000007788 liquid Substances 0.000 title 1
- 239000010410 layer Substances 0.000 claims description 60
- 206010072170 Skin wound Diseases 0.000 claims description 31
- 210000003491 skin Anatomy 0.000 claims description 28
- 238000004113 cell culture Methods 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 18
- 239000011159 matrix material Substances 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 14
- 239000000123 paper Substances 0.000 claims description 13
- 230000008929 regeneration Effects 0.000 claims description 12
- 238000011069 regeneration method Methods 0.000 claims description 12
- 210000004927 skin cell Anatomy 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 9
- 210000002950 fibroblast Anatomy 0.000 claims description 9
- 239000004745 nonwoven fabric Substances 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 8
- 230000008439 repair process Effects 0.000 claims description 8
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- 239000011176 biofiber Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 210000003953 foreskin Anatomy 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims description 5
- 239000004744 fabric Substances 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 108010081750 Reticulin Proteins 0.000 claims description 4
- 206010052428 Wound Diseases 0.000 claims description 4
- 208000027418 Wounds and injury Diseases 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000006260 foam Substances 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 229930182470 glycoside Natural products 0.000 claims description 4
- 239000002121 nanofiber Substances 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 229920006254 polymer film Polymers 0.000 claims description 4
- -1 vitamin C glycoside Chemical class 0.000 claims description 4
- 241001474374 Blennius Species 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000011550 stock solution Substances 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 238000011109 contamination Methods 0.000 claims 1
- 239000000499 gel Substances 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 230000037314 wound repair Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 102100032528 C-type lectin domain family 11 member A Human genes 0.000 description 4
- 101710167766 C-type lectin domain family 11 member A Proteins 0.000 description 4
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 4
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 230000033115 angiogenesis Effects 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 102000001301 EGF receptor Human genes 0.000 description 1
- 108060006698 EGF receptor Proteins 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000021403 epidermal cell division Effects 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 238000004078 waterproofing Methods 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Description
本創作係有關於一種具有幹細胞條件培養基組合液之微膠囊敷料,尤其是指一種包含敷料層、離型紙與覆蓋層,且該敷料層包含一基質與複數個分布於該基質中之微膠囊;且該微膠囊內含瓦頓氏凝膠間葉幹細胞(Wharton’s jelly mesenchymal stem cells(WJ-MSC))與人類包皮纖維母細胞(Human foreskin fibroblast cells)培養之條件培養基組合液之微膠囊敷料。 The present invention relates to a microcapsule dressing having a stem cell conditioned medium combination solution, in particular to a dressing layer, a release paper and a cover layer, and the dressing layer comprises a matrix and a plurality of microcapsules distributed in the matrix; The microcapsules comprise a microcapsule dressing of a conditioned medium combination solution of Wharton's jelly mesenchymal stem cells (WJ-MSC) and human foreskin fibroblast cells.
皮膚細胞再生能力與皮膚傷口修復和皮膚保養成效相關。不論適用於傷口修復或皮膚保養之敷料(即一般市售面膜),其結構至少包括一覆蓋層、一敷料層與一離型紙;差別在於覆蓋層與敷料層之材質與用途;作為皮膚傷口之修復的用途時,習知皮膚傷口敷料之覆蓋層的材質包括高分子薄膜、防水布、不織布、網狀纖維布、奈米纖維膜或聚合物(Polymeric)泡棉,覆蓋層可供空氣與水分通過、防止細菌進入且防止組織液滲出。而習知作為皮膚傷口覆蓋物之材質之基質包括:凝膠(Gel)或水膠(Hydrogel)、水膠片(Hydrocollo id)或海藻膠(Alginate)等;該基質可吸附皮膚傷口分泌之組織液與避免粘著皮膚傷口。然而,作為皮膚保養的用途時,該覆蓋層與敷料層可為習知作為面膜使用之紙類、不織布、生物纖維其中之一的材質;該覆蓋層可降低敷料乾燥速度且增加使用者對敷料內保養品成分之吸收,而敷料層係供保養品成分塗佈。 Skin cell regeneration is associated with skin wound repair and skin maintenance. Regardless of the dressing suitable for wound repair or skin care (ie, a commercially available facial mask), the structure includes at least a cover layer, a dressing layer and a release paper; the difference lies in the material and use of the cover layer and the dressing layer; For the purpose of repair, the material of the cover of the conventional skin wound dressing comprises a polymer film, a tarpaulin, a non-woven fabric, a reticular fiber cloth, a nanofiber film or a polymer (Polymeric foam), and the cover layer is available for air and moisture. Pass, prevent bacteria from entering and prevent exudation of tissue fluid. The substrate which is conventionally used as a material for skin wound coverings includes: gel or hydrogel, and water film (Hydrocollo). Id) or alginate (Alginate), etc.; the matrix can absorb tissue fluid secreted by skin wounds and avoid sticking to skin wounds. However, as a skin care application, the cover layer and the dressing layer may be a material of one of paper, non-woven fabric, and biofiber which are conventionally used as a mask; the cover layer can reduce the drying speed of the dressing and increase the user's dressing. The absorption of the inner care product component, and the dressing layer is applied to the skin care component.
一般市售皮膚傷口敷料多標榜有效防水與隔絕異物、且便於拆除不沾黏傷口。而醫療級的皮膚傷口敷料則藉由改善其使用之材質或添加某些成分(例如膠原蛋白促進細胞增生或銀離子增加殺菌功能)以促進傷口癒合。皮膚保養之敷料則添加保養品成分以促皮膚細胞再生,最終達抗皺與保濕之效果。習知覆蓋層與敷料層之材質如以上所述,研究開發者可藉由材質之選擇和/或額外成分之添加以達皮膚傷口修復或皮膚保養之效果,但是目前仍效果有限。為此,對於皮膚細胞再生之研究與應用具有其產業上之利用性。 Generally, the commercially available skin wound dressings are effectively labeled as waterproofing and isolating foreign matter, and are easy to remove non-stick wounds. Medical grade skin wound dressings promote wound healing by improving the materials used or by adding certain ingredients such as collagen to promote cell proliferation or silver ions to increase bactericidal function. Skin care dressings add skin care ingredients to promote skin cell regeneration, ultimately achieving anti-wrinkle and moisturizing effects. The materials of the conventional cover layer and the dressing layer are as described above, and the researcher can achieve the effect of skin wound repair or skin care by the choice of materials and/or the addition of additional ingredients, but the effect is still limited. For this reason, the research and application of skin cell regeneration has its industrial applicability.
此外,目前採行之方式僅限於單純於敷料上塗上添加物,但其缺點在於一段時間後有可能使各種添加物之間產生化學反應或變質之現象,即失去添加物之功效,故有必要找尋解決之道;故另外尋找一具有促進皮膚細胞再生之微膠囊敷料,並利用結合不同覆蓋層與敷料層之材質,達到一般、整形外科、外科手術皮膚傷口修復或皮膚保養無法達到之促進皮膚細胞再生效果者是為研究開發者所需努力之方向。 In addition, the current method is limited to simply applying the additive on the dressing, but the disadvantage is that after a period of time, it may cause a chemical reaction or deterioration between the various additives, that is, the effect of losing the additive, so it is necessary Looking for a solution; therefore, looking for a microcapsule dressing that promotes skin cell regeneration, and using a combination of different covering layers and dressing layers to achieve general, orthopedic, surgical skin wound repair or skin care can not achieve the promotion of the skin The effect of cell regeneration is the direction that researchers need to work hard.
今,創作人即是鑑於上述現有用於皮膚保養與皮膚傷口修復之敷料在實際實施上仍具有多處之缺失,於是乃一本孜孜不倦之精神,並藉由其豐富專業知識及多年實務經驗所輔佐而加以改善,並據此研創出本創作。 Nowadays, the creator is still in the practical implementation of the existing dressings for skin care and skin wound repair. It is a tireless spirit, and with its rich professional knowledge and years of practical experience. Accompanied by the improvement, and based on this research and creation of this creation.
本創作主要目的為提供一種本創作有關於具有幹細胞條件培養基組合液之微膠囊敷料,藉由該微膠囊敷料內含瓦頓氏凝膠間葉幹細胞與人類包皮纖維母細胞培養之條件培養基組合液促進皮膚細胞再生之能力以應用於皮膚保養與皮膚傷口之修復。 The main purpose of the present invention is to provide a microcapsule dressing having a stem cell conditioned medium composition solution, wherein the microcapsule dressing contains a conditioned medium combination solution of Wharton gel mesenchymal stem cells and human foreskin fibroblasts. The ability to promote skin cell regeneration for skin care and skin wound repair.
為了達到上述實施目的,本創作人提出具有幹細胞條件培養基組合液之微膠囊敷料,其係包含有:一包含一第一表面與一對應該第一表面之第二表面的敷料層、一平行疊合鋪設於該第一表面之上之離型紙以及一平行疊合鋪設於該第二表面之上之覆蓋層;使用時以該第一表面直接密合於使用者之皮膚,且該敷料層包含一基質與複數個分布於該基質中之微膠囊;其中該微膠囊係呈中空狀並形成一容置空間,且可於該容置空間內設入適量含有細胞培養之條件培養基組合液,用以促進皮膚細胞再生;此外,該離型紙之設置可避免該微膠囊敷料於未使用之狀況下受汙染;而該覆蓋層之設置可避免該微膠囊敷料於未使用之狀況下受汙染。 In order to achieve the above-mentioned object, the present inventors propose a microcapsule dressing having a stem cell conditioned medium composition solution, comprising: a dressing layer comprising a first surface and a pair of second surfaces corresponding to the first surface, a parallel stack a release paper laid on the first surface and a cover layer laminated on the second surface; the first surface is directly adhered to the skin of the user, and the dressing layer comprises a matrix and a plurality of microcapsules distributed in the matrix; wherein the microcapsules are hollow and form an accommodating space, and an appropriate amount of a conditioned medium composition containing cell culture can be disposed in the accommodating space. To promote skin cell regeneration; in addition, the release paper is arranged to prevent the microcapsule dressing from being contaminated under unused conditions; and the cover layer is disposed to prevent the microcapsule dressing from being contaminated under unused conditions.
在本創作的一實施例中,其中該覆蓋層與該敷料層間可進一步設置一感壓膠層,以增加該皮膚傷口與該微膠囊敷料間的密合度;再者,其中該覆蓋層可例如為高分子薄膜、防水布、不織布、網狀纖維布、奈米纖維膜或聚合物泡棉其中之一,以供空氣與水分通過、防止細菌進入且防止組織液滲出;此外,其中該基質 可例如為習知皮膚傷口覆蓋物之材質,包括凝膠、水膠、水膠片或海藻膠其中之一,以吸附皮膚傷口分泌之組織液、供微膠囊塗佈與避免粘著傷口;藉由上述材質之選擇以用於皮膚傷口之修復。 In an embodiment of the present invention, a pressure sensitive adhesive layer may be further disposed between the cover layer and the dressing layer to increase the adhesion between the skin wound and the microcapsule dressing; wherein, the cover layer may be, for example, It is one of a polymer film, a tarpaulin, a non-woven fabric, a reticular fiber cloth, a nanofiber membrane or a polymer foam for allowing air and moisture to pass through, preventing bacteria from entering and preventing exudation of tissue fluid; further, wherein the matrix For example, it may be a material of a conventional skin wound covering, including one of a gel, a water gel, a water film or a seaweed gel, for adsorbing tissue fluid secreted by a skin wound, for coating a microcapsule and avoiding a sticky wound; The choice of material is used for the repair of skin wounds.
在本創作的一實施例中,其中該覆蓋層可例如為紙類、不織布、生物纖維其中之一,以降低該微膠囊敷料乾燥速度且增加使用者對該微膠囊敷料內有效物質之吸收;再者,其中該基質係可例如為紙類、不織布或生物纖維其中之一以供該微膠囊塗佈;藉由上述材質之選擇以用於皮膚保養。 In an embodiment of the present invention, the cover layer may be, for example, one of paper, non-woven fabric, and biofiber to reduce the drying speed of the microcapsule dressing and increase the absorption of the effective substance in the microcapsule dressing by the user; Furthermore, the matrix may be, for example, one of paper, non-woven fabric or biofiber for coating the microcapsules; for the skin care by selection of the above materials.
在本創作的一實施例中,其中該微膠囊可由低溫溶解蠟所構成,且該低溫溶解蠟之熔點介於35℃至45℃之間。 In an embodiment of the present invention, wherein the microcapsules are composed of a low temperature dissolving wax, and the melting point of the low temperature dissolving wax is between 35 ° C and 45 ° C.
在本創作的一實施例中,其中該細胞培養之條件培養基包括瓦頓氏凝膠間葉幹細胞培養之條件培養基與人類包皮纖維母細胞培養之條件培養基;再者,其中該細胞培養之條件培養基之形式可例如為原液、濃縮液或粉末其中之一。 In an embodiment of the present invention, the conditioned medium for the cell culture comprises a conditioned medium of Wharton's mesenchymal stem cell culture and a conditioned medium for culture of human foreskin fibroblasts; and further, the conditioned medium for the cell culture The form may be, for example, one of a stock solution, a concentrate or a powder.
在本創作的一實施例中,其中形式為濃縮液的細胞培養之條件培養基組合液可進一步添加甘油、維生素C醣苷、人類寡胜肽-1、人類寡胜肽-3、人類寡胜肽-6或純水其中之一。 In an embodiment of the present invention, the conditioned medium composition solution for cell culture in the form of a concentrate may further add glycerin, vitamin C glycoside, human oligopeptide-1, human oligopeptide-3, human oligopeptide- 6 or one of pure water.
藉由該微膠囊敷料內含之該條件培養基可促進皮膚細胞再生;且藉由該覆蓋層與該敷料層材質之選擇可將該微膠囊敷料應用於皮膚保養與皮膚傷口之修復,以增加其產業利用性。 The conditioned medium contained in the microcapsule dressing can promote skin cell regeneration; and the microcapsule dressing can be applied to skin care and skin wound repair by selecting the cover layer and the material of the dressing layer to increase the Industrial utilization.
(1)‧‧‧覆蓋層 (1) ‧ ‧ cover layer
(2)‧‧‧敷料層 (2) ‧ ‧ dressing layer
(21)‧‧‧第一表面 (21) ‧‧‧ first surface
(22)‧‧‧第二表面 (22) ‧‧‧second surface
(23)‧‧‧基質 (23) ‧‧‧Matrix
(24)‧‧‧微膠囊 (24)‧‧‧microcapsules
(241)‧‧‧低溫溶解蠟 (241)‧‧‧Low-temperature dissolving wax
(242)‧‧‧容置空間 (242) ‧‧‧ accommodating space
(243)‧‧‧條件培養基組合液 (243) ‧‧‧Conditional medium combination solution
(3)‧‧‧離型紙 (3) ‧‧‧ release paper
第一圖:本創作較佳實施例之外觀分解圖 The first figure: an exploded view of the preferred embodiment of the present creation
第二圖:本創作較佳實施例之微囊體之結構示意圖 Second: Schematic diagram of the microcapsules of the preferred embodiment of the present invention
本創作之目的及其結構功能上的優點,將依據以下圖面所示之結構,配合具體實施例予以說明,俾使審查委員能對本創作有更深入且具體之瞭解。 The purpose of this creation and its structural and functional advantages will be explained in accordance with the structure shown in the following figure, in conjunction with specific examples, so that the review committee can have a deeper and more specific understanding of the creation.
首先,請同時參閱第一、二圖,係分別為本創作較佳實施例之外觀分解圖與較佳實施例之微膠囊之結構示意圖。本創作係具有幹細胞條件培養基組合液之微膠囊敷料至少包含:一敷料層(2),包含一第一表面(21)與一對應第一表面(21)之第二表面(22);敷料層(2)包含一基質(23)與複數個分布於基質(23)中之微膠囊(24);上述之微膠囊(24)係為中空狀並形成一容置空間(242),且可於上述之容置空間(242)內設入適量含有細胞培養之條件培養基組合液(243),用以促進皮膚細胞再生;一離型紙(3),平行疊合鋪設於第一表面(21)之上,可避免微膠囊敷料於未使用之狀況下受汙染;以及一覆蓋層(1),平行疊合鋪設於第二表面(22)之上,可避免微膠囊敷料於未使用之狀況下受汙染。 First, please refer to the first and second figures at the same time, which are respectively an exploded view of the preferred embodiment of the present invention and a schematic structural view of the microcapsule of the preferred embodiment. The present invention relates to a microcapsule dressing having a stem cell conditioned medium combination solution comprising at least: a dressing layer (2) comprising a first surface (21) and a second surface (22) corresponding to the first surface (21); a dressing layer (2) comprising a matrix (23) and a plurality of microcapsules (24) distributed in the matrix (23); the microcapsules (24) are hollow and form an accommodating space (242), and are The above-mentioned accommodation space (242) is provided with an appropriate amount of a conditioned medium composition solution (243) containing cell culture for promoting skin cell regeneration; a release paper (3) is placed on the first surface (21) in parallel. The microcapsule dressing can be prevented from being contaminated under the unused condition; and a cover layer (1) is placed on the second surface (22) in parallel, which can prevent the microcapsule dressing from being subjected to the unused condition. Pollution.
實際使用時,將接著離型紙(3)取下後,將第一表面(21)直接密合於使用者之皮膚,上述之微膠囊(24)可由低溫 溶解蠟(241)所構成,且低溫溶解蠟(241)之熔點介於35℃至45℃之間,利於使用時藉由體溫造成其內容物釋出;且細胞培養之條件培養基包括瓦頓氏凝膠間葉幹細胞培養之條件培養基與人類包皮纖維母細胞培養之條件培養基;文獻指出瓦頓氏凝膠間葉幹細胞培養之條件培養基內含多種人類生長因子,其中表皮生長因子(EGF)、鹼性纖維母細胞生長因子(b-FGF)和皮膚幹細胞生長因子(SCF)與皮膚細胞再生有關;然而,瓦頓氏凝膠間葉幹細胞培養之條件培養基內鹼性纖維母細胞生長因子相對含量較少,固可藉由添加內含較多鹼性纖維母細胞生長因子之人類包皮纖維母細胞培養之條件培養基加以補充;其中表皮生長因子結合在皮膚表皮的基底層細胞膜的表皮生長因子受體(EGFR)上,可加速表皮細胞分裂,且同時為膠原蛋白合成的主要動力元素,能有效生成並強化組織纖維,迅速改善皮膚代謝情況,幫助肌膚淺層、中層、深層組織細胞生長代謝,協同彈力纖維、膠原蛋白合成,達到抗皺嫩膚的作用;而鹼性纖維母細胞生長因子具有協助血管新生(angiogenesis)、傷口癒合的功能,且同時具有強化纖維母細胞(fibroblast)的功能,藉由刺激纖維母細胞,使纖維母細胞達到活化之目的;此外,皮膚幹細胞生長因子主要作用為誘導基底層幹細胞增生;細胞培養之條件培養基可是製程或效果之需求以原液、濃縮液或粉末其中之一的形式添加於含有細胞培養之條件培養基組合液(243)中,且調整其添加之比例。 In actual use, after the release paper (3) is removed, the first surface (21) is directly adhered to the skin of the user, and the microcapsule (24) can be low temperature. The dissolved wax (241) is composed, and the melting point of the low-temperature dissolving wax (241) is between 35 ° C and 45 ° C, which facilitates the release of its contents by body temperature during use; and the conditioned medium for cell culture includes Watson's Conditioned medium for gel mesenchymal stem cell culture and conditioned medium for culture of human foreskin fibroblasts; the literature indicates that the conditioned medium of Wharton's mesenchymal stem cell culture contains various human growth factors, including epidermal growth factor (EGF) and alkali. Fibroblast growth factor (b-FGF) and skin stem cell growth factor (SCF) are involved in skin cell regeneration; however, the relative content of basic fibroblast growth factor in conditioned medium of Wharton's mesenchymal stem cell culture is higher. Less, solid can be supplemented by the addition of conditioned medium cultured with human foreskin fibroblasts containing more basic fibroblast growth factor; epidermal growth factor binds to the epidermal growth factor receptor in the basal cell membrane of the skin epidermis ( EGFR) accelerates epidermal cell division and is the main driving element of collagen synthesis, which can effectively produce and strengthen tissue fibers. Vitamins, rapidly improve skin metabolism, help skin growth, metabolism in shallow, middle and deep tissues, synergize with elastic fibers and collagen to achieve anti-wrinkle and skin rejuvenation; and basic fibroblast growth factor assists angiogenesis (angiogenesis) ), the function of wound healing, and at the same time has the function of fibroblast, which stimulates fibroblasts to activate fibroblasts; in addition, skin stem cell growth factor mainly acts to induce basal stem cell proliferation The conditioned medium for cell culture may be added to the conditioned medium composition (243) containing the cell culture in the form of one of a stock solution, a concentrate or a powder, and the ratio of the addition thereof is adjusted.
再者,於形式為濃縮液的細胞培養之條件培養基組合液(2 43)中,可進一步添加甘油、維生素C醣苷、人類寡胜肽-1、人類寡胜肽-3、人類寡胜肽-6或純水其中之一之成分;其中,甘油可增加皮膚保溼;維生素C醣苷係維他命C後面再加上二個葡萄糖分子的誘導體,不僅具有維他命C其強大的還原力與抗氧化作用,且更具有較佳的安定性;而人類寡胜肽-1(俗稱的表皮生長因子)、人類寡胜肽-3(俗稱的鹼性纖維母細胞生長因子)和人類寡胜肽-6(俗稱之皮膚幹細胞生長因子)之添加則可針對單一成分進行補充與增強其效果。 Furthermore, a conditioned medium composition solution for cell culture in the form of a concentrate (2 In 43), a component of one of glycerin, vitamin C glycoside, human oligopeptide-1, human oligopeptide-3, human oligopeptide-6 or pure water may be further added; wherein glycerin may increase skin moisturization Vitamin C glycoside vitamin C is followed by an inducer of two glucose molecules, which not only has the strong reducing power and antioxidant effect of vitamin C, but also has better stability; and human oligopeptide-1 ( The addition of human oligopeptide-3 (commonly known as basic fibroblast growth factor) and human oligopeptide-6 (commonly known as skin stem cell growth factor) can be supplemented and enhanced for a single component. Its effect.
此外,微膠囊(24)可置於一塗物中以利於塗佈於基質(23)上,再藉由敷料層(2)與覆蓋層(1)材質之選擇可增加微膠囊敷料之產業利用性。 In addition, the microcapsules (24) can be placed in a coating to facilitate application to the substrate (23), and the selection of the material of the coating layer (2) and the covering layer (1) can increase the industrial utilization of the microcapsule dressing. Sex.
作為皮膚傷口之修復的用途時,覆蓋層(1)可為習知皮膚傷口敷料之覆蓋層(1)的材質,包括高分子薄膜、防水布、不織布、網狀纖維布、奈米纖維膜或聚合物泡棉其中之一;在此,覆蓋層(1)可供空氣與水分通過、防止細菌進入且防止組織液滲出,以用於皮膚傷口之修復。而基質(23)可為習知皮膚傷口覆蓋物之材質,包括:凝膠或水膠、水膠片或海藻膠其中之一;基質(23)可吸附皮膚傷口分泌之組織液、供微膠囊(24)塗佈與避免粘著傷口;藉由組合不同習知用於皮膚傷口敷料的敷料層(2)與覆蓋層(1)材質與調整添加含有細胞培養之條件培養基組合液(243)內成分之比例,此微膠囊敷料可使用於一般、整形外科或外科手術皮膚傷口修復。於上述覆蓋層(1)與敷料層(2)間可進一步設置一感壓膠層(圖中未標示), 感壓膠層係增加皮膚傷口與微膠囊敷料間的密合度以用於皮膚傷口之修復。 When used as a repair for skin wounds, the cover layer (1) may be a material of a cover layer (1) of a conventional skin wound dressing, including a polymer film, a tarpaulin, a non-woven fabric, a reticular fiber cloth, a nanofiber film or One of the polymer foams; here, the cover layer (1) is used for the passage of air and moisture, prevents the entry of bacteria and prevents the exudation of tissue fluid for the repair of skin wounds. The substrate (23) may be a material of a conventional skin wound covering, including: one of gel or water gel, water film or seaweed gum; the matrix (23) can adsorb tissue fluid secreted by the skin wound, for microcapsules (24) Applying and avoiding adhering wounds; adding ingredients in the conditioned medium composition (243) containing cell culture by combining different dressing layers (2) and cover layers (1) for conventional skin wound dressings In proportion, this microcapsule dressing can be used for general, orthopedic or surgical skin wound repair. A pressure sensitive adhesive layer (not shown) may be further disposed between the cover layer (1) and the dressing layer (2). The pressure sensitive adhesive layer increases the tightness between the skin wound and the microcapsule dressing for the repair of the skin wound.
然而,作為皮膚保養敷料之用途時,覆蓋層(1)與敷料層(2)可為習知作為皮膚保養敷料(面膜)使用之紙類、不織布、生物纖維其中之一的材質;覆蓋層(1)可降低微膠囊敷料乾燥速度且增加使用者對微膠囊敷料內有效物質之吸收;而基質(23)可供微膠囊(24)塗佈;藉由組合不同習知用於皮膚保養敷料的敷料層(2)與覆蓋層(1)材質與調整添加含有細胞培養之條件培養基組合液(243)內成分之比例,此微膠囊敷料可使用於皮膚保養之用途。 However, as a skin care dressing, the cover layer (1) and the dressing layer (2) may be a material of one of paper, non-woven fabric, and biofiber which are conventionally used as a skin care dressing (mask); 1) can reduce the drying speed of the microcapsule dressing and increase the absorption of the effective substance in the microcapsule dressing by the user; and the substrate (23) can be coated by the microcapsule (24); by combining different conventional skin care dressings The ratio of the material of the dressing layer (2) and the covering layer (1) to the composition of the conditioned medium combination solution (243) containing the cell culture can be used for skin care.
由上述之實施說明可知,本創作與現有技術相較之下,本創作具有以下優點: It can be seen from the above description that the present creation has the following advantages compared with the prior art:
1.本創作用使用之細胞培養之條件培養基內含多種生長因子且為細胞來源,較一般人工合成或是基因工程製造之生長因子貼近生理狀態。 1. The conditioned medium for cell culture used in the present invention contains various growth factors and is a cell source, which is close to the physiological state compared with the growth factors of general synthetic or genetic engineering.
2.本創作之微膠囊敷料可藉由內含之細胞培養之條件培養基促進皮膚細胞再生,且微膠囊利於其內含成分之保存。 2. The microcapsule dressing of the present invention can promote skin cell regeneration by the conditioned medium containing the cell culture, and the microcapsule facilitates the preservation of the contained components.
3.本創作之微膠囊敷料可藉由敷料層與覆蓋層材質之選擇以增加微膠囊敷料之產業利用性。 3. The microcapsule dressing of the present invention can increase the industrial applicability of the microcapsule dressing by selecting the material of the dressing layer and the covering layer.
綜上所述,本創作之微膠囊敷料,的確能藉由上述所揭露之實施例,達到所預期之使用功效,且本創作亦未曾公開於申請前,誠已完全符合專利法之規定與要求。爰依法提出新型專利之申請,懇請惠予審查,並賜准專利,則實感德便。 In summary, the microcapsule dressing of the present invention can achieve the intended use effect by the above disclosed embodiments, and the creation has not been disclosed before the application, and has fully complied with the requirements and requirements of the patent law. . If you apply for a new type of patent in accordance with the law, you are welcome to review it and grant a patent.
惟,上述所揭之圖示及說明,僅為本創作之較佳實施例,非為限定本創作之保護範圍;大凡熟悉該項技藝之人士,其所依本創作之特徵範疇,所作之其它等效變化或修飾,皆應視為不脫離本創作之設計範疇。 However, the illustrations and descriptions disclosed above are only preferred embodiments of the present invention, and are not intended to limit the scope of protection of the present invention; those who are familiar with the skill are otherwise characterized by the scope of the creation. Equivalent changes or modifications shall be considered as not departing from the design of this creation.
(1)‧‧‧覆蓋層 (1) ‧ ‧ cover layer
(2)‧‧‧敷料層 (2) ‧ ‧ dressing layer
(21)‧‧‧第一表面 (21) ‧‧‧ first surface
(22)‧‧‧第二表面 (22) ‧‧‧second surface
(23)‧‧‧基質 (23) ‧‧‧Matrix
(24)‧‧‧微膠囊 (24)‧‧‧microcapsules
(3)‧‧‧離型紙 (3) ‧‧‧ release paper
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW102210016U TWM464150U (en) | 2013-05-29 | 2013-05-29 | Microcapsule dressing containing stem cell conditioned medium composition liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW102210016U TWM464150U (en) | 2013-05-29 | 2013-05-29 | Microcapsule dressing containing stem cell conditioned medium composition liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TWM464150U true TWM464150U (en) | 2013-11-01 |
Family
ID=49991099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW102210016U TWM464150U (en) | 2013-05-29 | 2013-05-29 | Microcapsule dressing containing stem cell conditioned medium composition liquid |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWM464150U (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119405875A (en) * | 2024-10-31 | 2025-02-11 | 安徽中科生命谷科技有限公司 | Plant polysaccharide hydrogel medical dressing for promoting tissue damage repair and its application |
| TWI897693B (en) * | 2024-10-23 | 2025-09-11 | 國立臺中科技大學 | Wound dressing |
-
2013
- 2013-05-29 TW TW102210016U patent/TWM464150U/en not_active IP Right Cessation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI897693B (en) * | 2024-10-23 | 2025-09-11 | 國立臺中科技大學 | Wound dressing |
| CN119405875A (en) * | 2024-10-31 | 2025-02-11 | 安徽中科生命谷科技有限公司 | Plant polysaccharide hydrogel medical dressing for promoting tissue damage repair and its application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jiang et al. | Current status and progress in research on dressing management for diabetic foot ulcer | |
| Hosseini et al. | Skin biomechanics: a potential therapeutic intervention target to reduce scarring | |
| CN103083282A (en) | Novel hydrogel scar patch and its preparation process | |
| BRPI1106859A2 (en) | Degradation stabilized collagen arrays, biocompatible | |
| CN102850598B (en) | Alginate-gelatin-carboxymethylcellulose sodium blend membrane, and preparation and application thereof | |
| CN102138872B (en) | Chitosan lotion and preparation method thereof | |
| US20170197006A1 (en) | Honey-based foam compositions | |
| CN112545756A (en) | Preparation method of medical ozone oil-silicone foam patch | |
| CN204655268U (en) | A kind of alginate medical dressing | |
| EP3763396A1 (en) | Method for color maintenance and enhancement of tattoo | |
| CN103083712A (en) | Stem cells or other bioactive substances doped surgical dressing | |
| Yang et al. | Multifunctional hydrogels for wound healing | |
| CN206792707U (en) | A kind of composite foam electret dermal matrix dressing | |
| CN110623792B (en) | Medical dressing and preparation method thereof | |
| Zajicek et al. | New biological temporary skin cover Xe-Derma® in the treatment of superficial scald burns in children | |
| CN204521109U (en) | Medical macromolecular splint | |
| CN202682163U (en) | Double-layer hydrocolloid medical dressing | |
| CN211485243U (en) | Wound surface composite dressing containing bioactive glass | |
| CN202113231U (en) | Wound dressing | |
| CN205252141U (en) | Alginate gel woundplast of moisturizing | |
| CN205181863U (en) | Compound dressing of alginate non -woven fabrics | |
| WO2017026698A1 (en) | Keratin softening patch | |
| CN107029275A (en) | Wet dressing | |
| CN215080873U (en) | Three-dimensionally fitted wound applicator | |
| CN203154077U (en) | Skin packet patch |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4K | Annulment or lapse of a utility model due to non-payment of fees |